The role of melatonin treatment in chronic kidney disease.

Front Biosci (Landmark Ed)

Department of Hospital Pharmacy, Meander Medical Center, Amersfoort, The Netherlands.

Published: June 2012

The pineal hormone melatonin plays a major role in circadian sleep-wake rhythm. Patients with Chronic Kidney Disease (CKD), especially those who are on hemodialysis, frequently suffer from sleep disturbances. In this review an overview is given of the classification of stages of chronic kidney disease, followed by a presentation of the circadian rhythm disorders in renal disease involving sleep disturbances in relation to melatonin deficiency. The therapeutic benefit of melatonin treatment in sleep disorders related to chronic kidney disease including the controlled trials solving this topic, is described. Furthermore, the beneficial effect of melatonin on blood pressure alterations in CKD states and the protection of melatonin in oxidative stress and inflammation in renal disorders are explored. Finally a hypothetic model is described for the relation between circadian rhythm disorders and CKD.

Download full-text PDF

Source
http://dx.doi.org/10.2741/4075DOI Listing

Publication Analysis

Top Keywords

chronic kidney
16
kidney disease
16
melatonin treatment
8
sleep disturbances
8
circadian rhythm
8
rhythm disorders
8
disease
5
melatonin
5
role melatonin
4
chronic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!